1. Opening Hook
US tariffs struck again, pigments turned pale, APIs refused to cooperate, and yet management walked in smiling. If global chemicals are in ICU, Asahi Songwon says it’s already out of danger—just on oxygen support.
Q2 numbers disappointed, H1 barely held together, and investors got a masterclass in patience, geopolitics, and “long-term thinking.” Blue business sneezed because America coughed. AZO finally stopped bleeding. APIs… well, still learning how to walk.
But don’t leave yet. Somewhere between collapsing realizations, 15% plant utilization, and promises of 15%+ ROCE lies a story of hope, confidence, and very optimistic PowerPoint math.
Read on. It genuinely gets more interesting—and unintentionally funny—later.
2. At a Glance
- Revenue down 15% YoY – Global slowdown plus US tariffs doing tag-team wrestling.
- EBITDA down 23% YoY – Margins tried yoga, still stretched.
- EBITDA margin at 9% – Management calls it “resilient,” investors call it “meh.”
- Net profit down 35% – Profits followed exports to the US: vanished.
- Operating cash flow ₹36 Cr – Cash quietly working while P&L panics.
3. Management’s Key Commentary
“Global business conditions remain very, very challenging.”
(Translation: It’s bad everywhere, so please don’t blame us 😏)
“We did ₹60 crore EBITDA last year; this year we’ll do close to ₹50 crore.”
(Translation: Peak earnings already peaked.)
“US tariffs severely impacted our blue business.”
(Translation: One White House decision, entire pigment line caught cold.)
“ATC Dahej has turned cash positive after three years.”
(Translation: Finally stopped burning money—small miracles do happen 🎉)
“API plant utilization is just 15%.”
(Translation: World-class asset, currently on extended vacation.)
“Prices have bottomed out across pigments and APIs.”
(Translation: They can’t fall more… we hope 😬)
“We are confident ROCE will cross 15% in a few years.”
(Translation: Trust the process, not the timeline.)
4. Numbers Decoded
Metric Q2 FY26 YoY Change
---------------------------------------------------
Revenue ₹121 Cr -15%
EBITDA ₹11 Cr -23%
